Biosimilars: Forging a New Path to Accessibility Amid the Reshaping of the Global Biologics Industry
Article Date
March 25, 2026
This article is featured on another website.
Go to article
February 26, 2026
Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome
February 26, 2026
Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome
January 29, 2026
Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company
Overview A US biotech company's Phase I oncology study had stalled under the management of…
January 29, 2026
Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company
Overview A US biotech company's Phase I oncology study had stalled under the management of…